December 17, 2024
Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio
Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States as the first generic version of Epinephrine in a 1mg/1mL vial for U.S. customers.